Activation of Nrf2 and FXR via Natural Compounds in Liver Inflammatory Disease
International Journal of Molecular Sciences · 18.10.2024 · 25 (20) · 11213
DOI: 10.3390/ijms252011213 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.10.2024. Verfasst von Marta Belka und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Biochemistry, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznan, Poland. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Receptors, Cytoplasmic and Nuclear, Oxidative Stress. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Polish National Science Centre.
Abstract (Originalsprache)
Liver inflammation is frequently linked to oxidative stress and dysregulation of bile acid and fatty acid metabolism. This review focuses on the farnesoid X receptor (FXR), a critical regulator of bile acid homeostasis, and its interaction with the nuclear factor erythroid 2-related factor 2 (Nrf2), a key modulator of cellular defense against oxidative stress. The review explores the interplay between FXR and Nrf2 in liver inflammatory diseases, highlighting the potential therapeutic effects of natural FXR agonists. Specifically, compounds such as auraptene, cafestol, curcumin, fargesone A, hesperidin, lycopene, oleanolic acid, resveratrol, rutin, ursolic acid, and withaferin A are reviewed for their ability to modulate both the FXR and Nrf2 pathways. This article discusses their potential to alleviate liver inflammation, oxidative stress, and damage in diseases such as metabolic-associated fatty liver disease (MAFLD), cholestatic liver injury, and viral hepatitis. In addition, we address the molecular mechanisms driving liver inflammation, including oxidative stress, immune responses, and bile acid accumulation, while also summarizing relevant experimental models. This review emphasizes the promising therapeutic potential of targeting both the Nrf2 and FXR pathways using natural compounds, paving the way for future treatments for liver diseases. Finally, the limitations of the clinical application were indicated, and further research directions were proposed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Biochemistry, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznan, Poland.
- Doctoral School, Poznan University of Medical Sciences, Bukowska 70, 60-812 Poznan, Poland.
- Department of Pharmaceutical Chemistry, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznan, Poland.
ORCID-Profile: Marta Belka, Aleksandra Gostyńska-Stawna, Maciej Stawny, Violetta Krajka-Kuźniak
Förderung
- Polish National Science Centre
Zitieren
APA
Belka, M., Gostyńska-Stawna, A., Stawny, M., & Krajka-Kuźniak, V. (2024). Activation of Nrf2 and FXR via Natural Compounds in Liver Inflammatory Disease. International Journal of Molecular Sciences, 25(20), 11213. https://doi.org/10.3390/ijms252011213
Vancouver
Belka M, Gostyńska-Stawna A, Stawny M, Krajka-Kuźniak V. Activation of Nrf2 and FXR via Natural Compounds in Liver Inflammatory Disease. International Journal of Molecular Sciences. 2024;25(20):11213. doi:10.3390/ijms252011213
BibTeX
@article{Belka2024,
author = {Belka, Marta and Gostyńska-Stawna, Aleksandra and Stawny, Maciej and Krajka-Kuźniak, Violetta},
title = {Activation of Nrf2 and FXR via Natural Compounds in Liver Inflammatory Disease},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {20},
pages = {11213},
doi = {10.3390/ijms252011213}
}
EUVIMED